naion glp-1 news Ozempic® Lawsuit The question everyone is asking.

[DOI] [PubMed] [Google Scholar] 12.Andrews R.C., Walker B.R

That same month, the journal Science declared glucagon-like peptide-1 (GLP-1) weight loss drugs its Breakthrough of the Year, beating out commendable contenders such as new malaria and Alzheimers treatments, innovative climate change research on natural carbon pumps and artificial intelligence (AI) in improving weather forecasting

doi:10.1152/ajprenal.00316.2016 113

Su YC, Hung JH, Chang KC, et al

The incidence of acute pancreatitis, as confirmed by post-marketing monitoring data, are less than 0.1%, which is in line with the rates seen in the general diabetic population

Clinical Implications for Fat Loss and Muscle Preservation Together, the findings illustrate the substantial efficacy of GLP-1-based therapies on anthropometric indices associated with obesity